Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01976949 · ClinicalTrials.gov registry record · NA
Evaluation of a Social-networking Intervention to Reduce Cancer-related Distress
A NA study, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 347
- Enrollment target
NCT01976949: Completed NA study, sponsored by Loma Linda University.
NCT01976949 is a NA study that has completed, run by Loma Linda University. The registered enrollment target is 347 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01976949, a NA study, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 347 participants
- Enrollment target
Study Summary
It is hypothesized that the treatment group will show greater improvements in quality of life and mood disturbance compared to the control group and that greater levels of engagement with the intervention materials will be associated with greater improvements in mood and quality of life.
Primary Outcome
The OQ-45 measures the global functioning of a client and is composed of 3 subscales that measure subjective discomfort (intrapsychic functioning), interpersonal relationships, and social role performance. The OQ-45 has adequate internal consistency (a = .93) and reliability (r = .84) (Lambert, et al., 2004).
Interventions
- BEHAVIORAL online social-networking intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 347 participants |
| Start Date | 2009-07 |
| Est. Completion | 2014-05 |
| Phase | NA |
What the finished NCT01976949 record still lists
NCT01976949 is an interventional study that assigns participants to a tested intervention. The registered 347 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 1 intervention - of which online social-networking intervention is the first listed.
NCT01976949 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01976949 about?
NCT01976949 is a clinical study titled "Evaluation of a Social-networking Intervention to Reduce Cancer-related Distress". It is hypothesized that the treatment group will show greater improvements in quality of life and mood disturbance compared to the control group and that greater levels of engagement with the intervention materials will be associated with greater improvements in mood and quality of life.
What is the current status of trial NCT01976949?
This trial is currently completed. It is a NA study. The enrollment target is 347 participants. The study started on 2009-07. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01976949?
The interventions under investigation include: online social-networking intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01976949?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01976949's enrollment target sits among peer trials
347 302nd of 2000 higher than 1,699 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01742143 · 347 participants
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
- NCT04877522 · 347 participants · Phase 4
Asciminib Roll-over Study
- NCT05834660 · 347 participants · NA
SAFETY-A for Promoting Equity in Suicide Prevention Outcomes in Schools
- NCT06963827 · 347 participants · Phase 3
A Study of Mezagitamab in Adults With Primary IgA Nephropathy Kidney Condition
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia